Buys and sells from 最高の，を越す 分析家s

By THIS IS MONEY
Updated:

?

This week 仲買人s and 分析家s comment on the に引き続いて companies: GlaxoSmithKline, Signet.

28 December
UBS Warburg downgraded its 推薦 on UK-based jewellery retailer Signet Group to 'buy' from 'strong buy'. It also 削減（する） its price 的 for Signet 株 to 65p from 75p.

27 December
Credit Suisse First Boston started ニュース報道 of GlaxoSmithKline, the 製薬のs 巨大（な） formed by the 合併 of Glaxo Wellcome and SmithKline Beecham, with a 'buy' 推薦. The bank said in a 研究 公式文書，認める that its price 的 was 2100p and 追加するd that the 会社／堅い's 免疫 from market and 製品 危険 put it in a strong position. 'In our 見解（をとる）, the 株 look a 安全な 港／避難所 against an uncertain macroeconomic background,' the 公式文書，認める said.

Most watched Money ビデオs

MOST READ MONEY

Previous
Next
{"status":"error","code":"499","payload":"資産 id not 設立する: readcomments comments with assetId=1560202, assetTypeId=1"}